Sealing of the mediastinum with a local hemostyptic agent reduces chest tube duration after complete mediastinal lymph node dissection for stage I and II non-small cell lung carcinoma

Annals of Thoracic Surgery

Volumn 77, Issue 3, 2004, Pages 1028-1032

  Czerny, Martin ^a   Fleck, Tatjana ^a   Salat, Andreas ^a   Zimpfer, Daniel ^a   Klepetko, Walter ^a   Wolner, Ernst ^a   Mueller, Michael Rolf ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Waehringer Guertel 18 20   (Austria)

Author keywords

11

Indexed keywords

ANTICOAGULANT AGENT; DALTEPARIN; ENOXAPARIN; TACHOCOMB; TISSUE ADHESIVE;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTRACHEAL TUBE; FACTORIAL ANALYSIS; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; MEDIASTINUM LYMPH NODE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; THORAX DRAINAGE; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TREATMENT OUTCOME; TUBE;

EID: 1442324646     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2003.08.041     Document Type: Article

References (23)

1. Marshall M.B., Deeb M.E., Bleier J.I., et al. Suction vs water seal after pulmonary resection a randomized prospective study. Chest. 121:2002;831-835.
2. Cerfolio R.J., Bass C., Katholi C.R. Prospective randomized trial compares suction versus water seal for air leaks. Ann Thorac Surg. 71:2001;1613-1617.
3. Martino K., Merrit S., Boyakye K., et al. Prospective randomized trial of thoracostomy removal algorithms. J Trauma. 46:1999;369-371.
4. Davis J.W., Mackersie R.C., Hoyt D.B., Garcia J. Randomized study of algorithms for discontinuing tube thoracostomy drainage. J Am Coll Surg. 179:1994;553-557.
5. Cerfolio R.J., Pickens A., Bass C., Katholi C. Fast-tracking pulmonary resections. J Thorac Cardiovasc Surg. 122:2001;318-324.
6. Cerfolio R.J., Tummala R.P., Holman W.L., et al. A prospective algorithm of the management of air leaks after pulmonary resection. Ann Thorac Surg. 66:1998;1726-1731.
7. Nomori H., Horio H., Suemasu K. Anterior limited thoracotomy with intrathoracic illumination for lung cancer its advantages over anteroaxillary and posterolateral thoracotomy. Chest. 115:1999;874-880.
8. Carbon R.T., Baar S., Waldschmidt J., Huemmer H.P., Simon S.I. Innovative minimally invasive pediatric surgery is of therapeutic value for splenic injury. J Pediatr Surg. 37:2002;1146-1150.
9. Izbicki J.R., Kreusser T., Meier M., et al. Fibrin-glue-coated collagen fleece in lung surgery - experimental comparison with infrared coagulation, and clinical experience. Thorac Cardiovasc Surg. 42:1994;306-309.
10. Voormolen J.H., Ringers J., Bots G.T., van der Heide A., Hermans J. Hemostatic agents brain tissue reaction and effectiveness. A comparative animal study using collagen fleece and oxidized cellulose. Neurosurgery. 20:1987;702-709.
11. Schelling G., Block T., Blanke E., Hammer C., Brendel W., Gokel M. The effectiveness of a fibrinogen-thrombin-collagen-based hemostatic agent in an experimental arterial bleeding model. Ann Surg. 205:1987;432-435.
12. Czerny M., Verrel F., Weber H., et al. A randomised open multicenter study to evaluate safety and efficacy of TachoComb H in the treatment of suture hole bleedings compared to surgical compresses in vascular reconstructions using PTFE grafts. J Cardiovascular Surgery. 41:2000;553-557.
13. Leak L.V., Saunders M., Day A.A., Jones M. Stimulation of plasminogen activator and inhibitor in the lymphatic endothelium. Microvasc Res. 60:2000;201-211.
14. Ziomek S., Read R.C., Tobler H.G., et al. Thromboembolism in patients undergoing thoracotomy. Ann Thorac Surg. 56:1993;223-226.
15. Caprini J.A., Arcelus J., Sehgal L.R., Cohen E.B., Reyna J.J. The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States. Int Angiol. 21:2002;78-85.
16. Keller S.M., Adak S., Wagner H., Johnson D.H. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group. Ann Thorac Surg. 70:2000;358-365.
17. Byar D.P., Piantadosi S. Factorial design for randomized clinical trials. Cancer Treat Rep. 69:1985;1055-1063.
18. Jaquiss R.D., Ghanayem N.S., Zacharisen M.C., Mussatto K.A., Tweddell J.S., Litwin S.B. Safety of aprotinin use and re-use in pediatric cardiothoracic surgery. Circulation. 24:(12 Suppl 1):2002;I-90-94.
19. Dietrich W., Spath P., Zuhlsdorf M., et al. Anaphylactic reactions to aprotinin reexposure in cardiac surgery relation to antiaprotinin immunoglobulin G and E antibodies. Anesthesiology. 95:2001;64-71.
20. Hirsch J., Levine M.N. Low molecular weight heparin. Blood. 79:1992;1-17.
21. Collignon F., Frydman A., Caplain H., et al. Comparison of pharmacokinetic profiles of three low molecular mass heparins - dalteparin, enoxaparin and nadroparin - administered subcutaneously in healthy volunteers (doses for prevention of thromboembolism). Thromb Haemost. 73:1995;630-640.
22. Verstraete M. Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins. Drugs. 40:1990;498-530.
23. Bara L., Bloch M.F., Zitoun D., et al. Comparative effects of enoxaparin and unfractionated hepatin in healthy volunteers on prothrombin consumption in whole blood during coagulation, and release of tissue factor pathway inhibitor. Thromb Res. 69:1993;443-452.